Vascular Therapies announced that it closed an upsized private funding round worth more than $17 million with contributions from new and existing investors.
The Cresskill, N.J.–based clinical-stage biopharma company originally targeted $15 million for the financing, but finished with a total of $17.3 million raised.
Get the full story at our sister site, MassDevice.
Filed Under: Drug Delivery
Tell Us What You Think!
You must be logged in to post a comment.